Sarcopenia Identification Using Alternative Vertebral Landmarks in Individuals with Lung Cancer
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
(1) Background: Sarcopenia, or low skeletal mass index (SMI), contributes to higher lung cancer mortality. The SMI at third lumbar vertebrae (L3) is the reference standard for body composition analysis. However, there is a need to explore the validity of alternative landmarks in this population. We compared the agreement of sarcopenia identification at the first lumbar (L1) and second lumbar (L2) to L3 in non-Hispanic Black (NHB) and White (NHW) individuals with lung cancer. (2) Methods: This retrospective, cross-sectional study included 214 NHB and NHW adults with lung cancer. CT scans were analyzed to calculate the SMI at L1, L2, and L3. T-tests, chi-square, Pearson’s correlation, Cohen’s kappa, sensitivity, and specificity analysis were used. (3) Results: Subjects presented with a mean age of 68.4 ± 9.9 years and BMI of 26.3 ± 6.0 kg/m2. Sarcopenia prevalence varied from 19.6% at L1 to 39.7% at L3. Cohen’s kappa coefficient was 0.46 for L1 and 0.64 for L2, indicating weak and moderate agreement for the identification of sarcopenia compared to L3. (4) Conclusions: Sarcopenia prevalence varied greatly depending on the vertebral landmark used for assessment. Using L2 or L1 alone resulted in a 16.8% and 23.8% misclassification of sarcopenia in this cohort of individuals with lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CT stands out as the gold standard for muscle mass evaluation, typically performed at the third lumbar vertebra (L3).”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [11]
In the citing paper
“Multiple studies have demonstrated strong concordance and correlation between T12-derived SMI and standard L3-based measurements, supporting the validity of these alternative thoracic levels for Sc assessment [11,12,13].”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Derstine, B. A., Holcombe, S. A., Ross, B. E., Wang, N. C., Su, G. L., & Wang, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29825-5 · Cited by 507 · cited 9×
“Previous studies in healthy adults [6,11] and in those with lung cancer [8,9] indicate that skeletal muscle at the first lumbar vertebra (L1) or the second lumbar vertebra (L2) may be appropriate alternatives to L3 for sarcopenia analysis as they are highly correlated with the reference landmark.”
BackgroundMethodResultInfluential
Research works printed but not linked: 27
- Go, 2016, Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer, Support. Care Cancer, 24, 2075, 10.1007/s00520-015-2997-x · DOI
- Takamori, 2018, Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer, Ann. Surg. Oncol., 25, 1229, 10.1245/s10434-017-6328-y · DOI · Paper page
- Kinsey, 2017, Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung Cancer, Cancer Epidemiol. Biomark. Prev., 26, 38, 10.1158/1055-9965.EPI-15-1067 · DOI
- Troschel, 2020, Computed Tomography-based Body Composition Analysis and Its Role in Lung Cancer Care, J. Thorac. Imaging, 35, 91, 10.1097/RTI.0000000000000428 · DOI
- Shen, 2004, Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image, J. Appl. Physiol., 97, 2333, 10.1152/japplphysiol.00744.2004 · DOI · Paper page
- Mourtzakis, 2008, A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl. Physiol. Nutr. Metab., 33, 997, 10.1139/H08-075 · DOI · Paper page
- Kim, 2016, Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT, Support. Care Cancer, 24, 4721, 10.1007/s00520-016-3321-0 · DOI
- Galeas, 2018, Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT), Support. Care Cancer, 26, 2353, 10.1007/s00520-018-4051-2 · DOI
- Vangelov, 2022, The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: A systematic review, Br. J. Nutr., 127, 722, 10.1017/S0007114521001446 · DOI · Paper page
- Silva, 2010, Ethnicity-related skeletal muscle differences across the lifespan, Am. J. Hum. Biol., 22, 76, 10.1002/ajhb.20956 · DOI · Paper page
- Heymsfield, S.B., Hwaung, P., Ferreyro-Bravo, F., Heo, M., Thomas, D.M., and Schuna, J.M. (2019). Scaling of adult human bone and skeletal muscle mass to height in the US population. population. Am. J. Hum. Biol., 31. · DOI
- Xiao, 2019, The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer, Am. J. Clin. Nutr., 109, 615, 10.1093/ajcn/nqy328 · DOI
- Parsons, H.A., Baracos, V.E., Dhillon, N., Hong, D.S., Kurzrock, R., and Deutsch, E. (2012). Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS ONE, 7. · DOI · Paper page
- Sheean, 2021, Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer, Breast Cancer Res. Treat., 190, 121, 10.1007/s10549-021-06358-6 · DOI
- Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study, Lancet Oncol., 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
- Martin, 2013, Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J. Clin. Oncol., 31, 1539, 10.1200/JCO.2012.45.2722 · DOI · Paper page
- Fearon, 2011, Definition and classification of cancer cachexia: An international consensus, Lancet Oncol., 12, 489, 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- Sanders, 2019, Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer, Int. J. Chronic Obstr. Pulm. Dis., 14, 781, 10.2147/COPD.S194003 · DOI
- McHugh, 2012, Interrater reliability: The kappa statistic, Biochem. Med., 22, 276, 10.11613/BM.2012.031 · DOI · Paper page
- Mandrekar, 2010, Receiver operating characteristic curve in diagnostic test assessment, J. Thorac. Oncol., 5, 1315, 10.1097/JTO.0b013e3181ec173d · DOI · Paper page
- Baratloo, 2015, Part 1: Simple Definition and Calculation of Accuracy, Sensitivity and Specificity, Emergency, 3, 48
- Derstine, 2021, Optimal body size adjustment of L3 CT skeletal muscle area for sarcopenia assessment, Sci. Rep., 11, 279, 10.1038/s41598-020-79471-z · DOI
- Burns, 2020, A Machine Learning Algorithm to Estimate Sarcopenia on Abdominal CT, Acad. Radiol., 27, 311, 10.1016/j.acra.2019.03.011 · DOI
- Baracos, 2010, Body composition in patients with non-small cell lung cancer: A contemporary view of cancer cachexia with the use of computed tomography image analysis, Am. J. Clin. Nutr., 91, 1133S, 10.3945/ajcn.2010.28608C · DOI · Paper page
- Zhang, 2016, Incidence and risk factor analysis for sarcopenia in patients with cancer, Oncol. Lett., 11, 1230, 10.3892/ol.2015.4019 · DOI
- Mitsiopoulos, 1998, Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, J. Appl. Physiol., 85, 115, 10.1152/jappl.1998.85.1.115 · DOI · Paper page
- Baeyens, 2010, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing, 39, 412, 10.1093/ageing/afq034 · DOI · Paper page
Cited by
Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., et al. (2025) · Cancers · doi:10.3390/cancers17193255 · Cited by 7
Metadata
- Authors
- Byrne, C. A., Fantuzzi, G., Stephan, J. T., Kim, S., Oddo, V. M., Koh, T. J., & Gomez, S. L.
- Affiliations
- Cancer Health Equity and Career Development Program, University of Illinois Chicago, 1747 W. Roosevelt Rd., Chicago, IL 60608, USA
- Department of Kinesiology and Nutrition, University of Illinois Chicago, 1919 W. Taylor St., Chicago, IL 60612, USA
- Department of Radiology, Rush University Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612, USA
- School of Public Health, University of Illinois Chicago, 1603 W. Taylor St., Chicago, IL 60612, USA
- Department of Clinical Nutrition, Rush University, 600 S. Paulina St., Chicago, IL 60612, USA
- Venue
- Muscles
- Publisher
- MDPI AG
- Published
- 2024-04-16
- Volume
- 3
- Issue
- 2
- Pages
- 121-132
- ISSN
- 2813-0413
- Cited by
- 4
- References
- 2
- Language
- en
- Funders
- National Cancer Institute (T32CA057699)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.